Blocknomi
Key Highlights Novo Nordisk shares declined more than 9% following disappointing ZEUS cardiovascular trial outcomes. The study demonstrated reduced inflammation markers but failed to decrease major heart-related events. The experimental…
Related articles
-
3M (MMM) Stock Surges 8% Following Microsoft Azure Partnership and Strong Q2 Earnings
Blocknomi Published 26.07.2026 09:42
-
A quantum roadmap would push Bitcoin much higher: Charles Edwards
Cointelegraph Published 24.07.2026 13:30
-
Shiba Inu (SHIB) Explodes 36% Higher in Weekend Rally Driven by Korean Markets and Whale Comeback
Blocknomi Published 26.07.2026 08:38
-
Ripple bought a bank in pieces. Here is the $4 billion audit
Crypto.News Published 25.07.2026 18:26
-
Anthropic’s $1.5B AI Copyright Deal Gets Court Approval in Historic Settlement
Blocknomi Published 21.07.2026 08:55
-
Solana (SOL) Price: Trades at $74 With $1.86B in 24-Hour Volume
Blocknomi Published 31.07.2026 10:18
-
Bernstein sees 78% upside for Robinhood as tokenization, prediction markets expand its crypto business
The Block Published 31.07.2026 10:43
-
UK Treasury races to solve cash barrier before tokenized bond debut
Crypto.News Published 22.07.2026 21:51